These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9200994)

  • 1. Risk factors for capillary leakage syndrome after bone marrow transplantation.
    Nürnberger W; Willers R; Burdach S; Göbel U
    Ann Hematol; 1997 May; 74(5):221-4. PubMed ID: 9200994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marrow engraftment and clinical manifestations of capillary leak syndrome.
    Cahill RA; Spitzer TR; Mazumder A
    Bone Marrow Transplant; 1996 Jul; 18(1):177-84. PubMed ID: 8832012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic growth factors in bone marrow transplantation.
    Mertelsmann R; Herrmann F; Hecht T; Schulz G
    Bone Marrow Transplant; 1990 Aug; 6(2):73-7. PubMed ID: 1698494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
    Hahn T; Alam AR; Lawrence D; Ford L; Baer MR; Bambach B; Bernstein ZP; Czuczman MS; Silva J; Slack JL; Wetzler M; Becker J; McCarthy PL
    Transplantation; 2004 Nov; 78(10):1515-22. PubMed ID: 15599317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hematopoietic growth factors in marrow transplantation.
    Nemunaitis J
    Curr Opin Oncol; 1994 Mar; 6(2):139-45. PubMed ID: 7516712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation.
    Nürnberger W; Heying R; Burdach S; Göbel U
    Ann Hematol; 1997 Sep; 75(3):95-101. PubMed ID: 9368478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
    Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
    Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
    Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, risk factors, and prognosis of capillary leak syndrome in pediatric recipients of stem cell transplants: a retrospective single-center cohort study.
    Lucchini G; Willasch AM; Daniel J; Soerensen J; Jarisch A; Bakhtiar S; Rettinger E; Brandt J; Klingebiel T; Bader P
    Pediatr Transplant; 2016 Dec; 20(8):1132-1136. PubMed ID: 27734564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor-associated histiocytosis and capillary-leak syndrome following autologous bone marrow transplantation: two case reports and a review of the literature.
    Al-Homaidhi A; Prince HM; Al-Zahrani H; Doucette D; Keating A
    Bone Marrow Transplant; 1998 Jan; 21(2):209-14. PubMed ID: 9489640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of haematopoietic growth factors in bone marrow transplantation.
    Polli EE
    Acta Haematol; 1991; 86(3):155-61. PubMed ID: 1723825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts.
    Mehta J; Powles R; Singhal S; Horton C; Middleton G; Eisen T; Meller S; Pinkerton CR; Treleaven J
    Bone Marrow Transplant; 1997 Feb; 19(4):349-55. PubMed ID: 9051245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic marrow transplantation and the use of hematopoietic growth factors.
    Appelbaum FR
    Stem Cells; 1995 Jul; 13(4):344-50. PubMed ID: 7549892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of recombinant human granulocyte macrophage colony-stimulating factor in autologous and allogeneic bone marrow transplantation.
    Nemunaitis J; Singer JW
    Cancer Invest; 1993; 11(2):224-8. PubMed ID: 8462023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.
    Isola LM; Scigliano E; Skerrett D; Shank B; Ross V; Najfeld V; Fruchtman S
    Bone Marrow Transplant; 1997 Dec; 20(12):1033-7. PubMed ID: 9466275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.